234 related articles for article (PubMed ID: 3327450)
1. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
Frénoy N; Schauffler J; Cahour A; Burtin P
Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
Kuroki M; Kuroki M; Koga Y; Matsuoka Y
J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
[TBL] [Abstract][Full Text] [Related]
3. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
Burtin P; Chavanel G; Hendrick JC; Frenoy N
J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
[TBL] [Abstract][Full Text] [Related]
6. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
Ichiki S; Kuroki M; Kuroki M; Koga Y; Matsuoka Y
Jpn J Cancer Res; 1986 May; 77(5):462-72. PubMed ID: 2426231
[TBL] [Abstract][Full Text] [Related]
7. Production of monoclonal antibodies against the non-specific cross-reacting antigen (NCA).
Chavanel G; Frenoy N; Escribano MJ; Burtin P
Oncodev Biol Med; 1983; 4(3):209-17. PubMed ID: 6402767
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
9. Two CEA cross-reacting antigens: differences in absorbing the same anti-CEA serum.
Ferrara RM; Biancardi C; Cavalca V; Botta M; Bailo M; Bartorelli A
Cancer Detect Prev; 1987; 10(1-2):101-8. PubMed ID: 3568003
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
11. Characterization of carcinoembryonic antigen-specific monoclonal antibodies and specific carcinoembryonic antigen assay in sera of patients.
Kitagawa H; Ohkouchi E; Fukuda A; Imai K; Yachi A
Jpn J Cancer Res; 1986 Sep; 77(9):922-30. PubMed ID: 2429946
[TBL] [Abstract][Full Text] [Related]
12. Affinity in radioimmunoassay of antibody cross-reactive with carcinoembryonic antigen (CEA) and colon carcinoma antigen-III (CCA-III).
Primus FJ; Newman ES; Hansen HJ
J Immunol; 1977 Jan; 118(1):55-61. PubMed ID: 63521
[TBL] [Abstract][Full Text] [Related]
13. The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
Ross DD; Gao Y; Yang W; Leszyk J; Shively J; Doyle LA
Cancer Res; 1997 Dec; 57(24):5460-4. PubMed ID: 9407950
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system.
Kuroki M; Arakawa F; Higuchi H; Matsunaga A; Okamoto N; Takakura K; Matsuoka Y
Jpn J Cancer Res; 1987 Apr; 78(4):386-96. PubMed ID: 2438262
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of monoclonal antibodies against carcinoembryonic antigen (CEA).
Jantscheff P; Böttger V; Price M; Micheel B; Kaiser G; Zotter S; Kotzsch M; Grossmann H; Karsten U
Biomed Biochim Acta; 1991; 50(12):1261-7. PubMed ID: 1824544
[TBL] [Abstract][Full Text] [Related]
16. CEA and NCA levels in peripheral and tumour venous blood of patients with gastric and colonic carcinomas estimated by RIA and EIA methods.
Harłozińska A; Rachel F; Gawlikowski W; Richter R; Kołodziej J
Eur J Surg Oncol; 1991 Feb; 17(1):59-64. PubMed ID: 1995360
[TBL] [Abstract][Full Text] [Related]
17. [Antigenic structures of CEA and CEA-related normal antigens and problems related to the determination of blood CEA concentrations].
Matsuoka Y; Kuroki M; Koga Y
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):575-84. PubMed ID: 6192762
[TBL] [Abstract][Full Text] [Related]
18. Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker.
Kuroki M; Matsushita H; Matsumoto H; Hirose Y; Senba T; Yamamoto T
Anticancer Res; 1999; 19(6C):5599-606. PubMed ID: 10697625
[TBL] [Abstract][Full Text] [Related]
19. Antigenic heterogeneity of carcinoembryonic antigen in the circulation defined by monoclonal antibodies against the carbohydrate moiety of carcinoembryonic antigen and closely related antigens.
Matsunaga A; Kuroki M; Higuchi H; Arakawa F; Takakura K; Okamoto N; Matsuoka Y
Cancer Res; 1987 Jan; 47(1):56-61. PubMed ID: 2431767
[TBL] [Abstract][Full Text] [Related]
20. Antigenic reactivities of purified preparations of carcinoembryonic antigen (CEA) and related normal antigens using four different radioimmunoassay systems for CEA.
Kuroki M; Yamaguchi A; Koga Y; Matsuoka Y
J Immunol Methods; 1983 May; 60(1-2):221-33. PubMed ID: 6406604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
